INDEPENDENT AUDITOR'S CONSENT

EXHIBIT 23.1

Independent Auditors' Consent

The Board of Directors and Stockholders
of Access Pharmaceuticals, Inc.

We consent to the incorporation by reference in
Registration Statement Nos. 33-42052, 33-32137 and 33-
22750 on Form S-3 and in Registration Statement Nos.
33-10626 and 33-41134 on Form S-8 of Access
Pharmaceuticals, Inc. (formerly Chemex
Pharmaceuticals, Inc.) of our report dated March 24,
1998, relating to the consolidated balance sheets of Access
Pharmaceuticals, Inc. and subsidiary as of December
31, 1997 and 1996, and the related consolidated
statements of operations, stockholders' equity and
cash flows for each of the years in the three-year
period ended December 31, 1997, which report appears
in the December 31, 1997 annual report on Form 10-K of
Access Pharmaceuticals, Inc.

Our report dated March 24, 1998, contains an
explanatory paragraph that states that the Company has
suffered recurring losses from operations and has a
net capital deficiency, which raise substantial doubt
about its ability to continue as a going concern. The
consolidated financial statements do not include any adjustments
that might result from the outcome of that
uncertainty.



/s/ KPMG Peat Marwick LLP
- --------------------------
KPMG Peat Marwick LLP


Dallas, Texas
March 24, 1998